RSS Feeds
Hyperthyroidism
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
I enjoyed the article by Klein and associates [1] on the management of hyperthyroidism. However, I was surprised by their statement that anticoagulation with warfarin is not routinely recommended to prevent arterial thromboembolism in patients with hyperthyroidism and atrial fibrillation who do not have organic heart disease (mitral valve disease) or congestive heart failure. This statement is not consistent with data that the reported frequency of arterial thromboembolism exceeds that of congestive heart failure or mitral valve disease in patients with hyperthyroidism [2-4]. Given the devastating effect of arterial thromboembolism and the documented protective effects of anticoagulation, it seems prudent to routinely recommend warfarin treatment unless contraindications to its use exist.
Kenneth A. Woeber
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright ©2004 by the American College of Physicians
